Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Rating Upgraded by Sanford C. Bernstein

Reckitt Benckiser Group (OTCMKTS:RBGLY) was upgraded by analysts at Sanford C. Bernstein from a “hold” rating to a “strong-buy” rating in a report released on Thursday,Zacks.com reports.

Separately, Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and four have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Reckitt Benckiser Group currently has an average rating of “Buy”.

Reckitt Benckiser Group Stock Down 0.2%

Shares of OTCMKTS RBGLY opened at $13.89 on Thursday. Reckitt Benckiser Group has a 1 year low of $10.43 and a 1 year high of $14.10. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. The stock’s 50-day simple moving average is $13.08 and its 200-day simple moving average is $12.87.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.